Status:
COMPLETED
Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
17+ years
Brief Summary
RATIONALE: Measuring the amount of prostaglandin metabolite in urine samples and studying tissue samples in the laboratory from patients with ovarian cancer may help doctors identify and learn more ab...
Detailed Description
OBJECTIVES: * Determine the level of prostaglandin E\_2 metabolite (PGE-M) in 24-hour urine samples collected prior to surgery or chemotherapy from patients with ovarian cancer. * Determine cyclooxyg...
Eligibility Criteria
Inclusion
- Diagnosis of known or suspected ovarian cancer
- Age greater than 17 years
Exclusion
- Pregnant or nursing
- Taking steroids or non-steroidal anti-inflammatory drugs (NSAIDs) on a regular basis.
- PRIOR CONCURRENT THERAPY:
- No concurrent chronic use of steroids or NSAIDs
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00900523
Start Date
November 1 2006
End Date
July 1 2008
Last Update
April 18 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.